Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 73, Issue 21-22, 2010, Pages 1420-1430

  Kim, Kyu Bong ^a   Yang, Ji Young ^b,c   Kwack, Seung Jun ^d   Park, Kui Lea ^d   Kim, Hyung Sik ^e   Ryu, Do Hyun ^f   Kim, Yeon Joo ^g   Hwang, Geum Sook ^b,c   Lee, Byung Mu ^g  

^a Inje University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Chungnam National University   (South Korea)

^d Korea Food and Drug Administration   (South Korea)

^e Pusan National University   (South Korea)

^f Department of Chemistry ^*  (Belarus)

^g Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; CITRIC ACID; HIPPURIC ACID; INDICAN; TRIMETHYLAMINE OXIDE; ALPHA-KETOGLUTARIC ACID; HIPPURIC ACID DERIVATIVE; METHYLAMINE; TRIMETHYLOXAMINE; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CANCER SIZE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STOMACH CANCER; STOMACH CARCINOGENESIS; TOXICOKINETICS; TOXICOMETABOLOMICS; TUMOR XENOGRAFT; URINALYSIS; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; DISCRIMINANT ANALYSIS; DISEASE MODEL; DRUG SCREENING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUDE MOUSE; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; STOMACH NEOPLASMS; TUMOR CELL LINE; URINE;

MUS;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CITRIC ACID; DISCRIMINANT ANALYSIS; DISEASE MODELS, ANIMAL; HIPPURATES; HUMANS; INDICAN; KETOGLUTARIC ACIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; METHYLAMINES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PRINCIPAL COMPONENT ANALYSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77958169142     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2010.511545     Document Type: Article

References (48)

1. Albert, D. M., Plum, L. A., Yang, W., Marcet, M., Lindstrom, M. J., Clagett-Dame, M., and DeLuca, H. F. 2005. Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor vitamin D analog. J. Steroid Biochem. Mol. Biol. 97:165-172.
2. Azab, S. S., Salama, S. A., Hassan, M. H., Khalifa, A. E., El-Demerdash, E., Fouad, H., Al-Hendy, A., and Abdel-Naim, A. B. 2008. 2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft. Cancer Chemother. Pharmacol. 62:893-902.
3. Baba, M., Inoue, M., Itoh, K., and Nishizawa, Y. 2008. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism. Biochem. Biophys. Res. Commun. 374:111-116.
4. Bhargava, S., Hotz, B., Buhr, H. J., and Hotz, H. G. 2009. An orthotopic nude mouse model for preclinical research of gastric cardia cancer. Int. J. Colorectal Dis. 24:31-39.
5. Bryan, K., Brennan, L., and Cunningham, P. 2008. MetaFIND: A feature analysis tool for metabolomics data. BMC Bioinformatics 9:470-482.
6. Chan, D. C., Chen, C. J., Chu, H. C., Chang, W. K., Yu, J. C., Chen, Y. J., Wen, L. L., Huang, S. C., Ku, C. H., Liu, Y. C., and Chen, J. H. 2007. Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann. Surg. Oncol. 14:84-93.
7. Correa, P. 1988. A human model of gastric carcinogenesis. Cancer Res. 48:3554-3560.
8. De Castro, J., Rodriguez, M. C., Martinez-Zorzano, V. S., Hernandez-Hernandez, A., Llanillo, M., and Sanchez-Yague, J. 2008. Erythrocyte and platelet phospholipid fatty acids as markers of advanced non-small cell lung cancer: Comparison with serum levels of sialic acid, TPS and Cyfra 21-1. Cancer Invest. 26:407-418.
9. De Soto, J. A., Wang, X., Tominaga, Y., Wang, R. H., Cao, L., Qiao, W., Li, C., Xu, X., Skoumbourdis, A. P., Prindiville, S. A., Thomas, C. J., and Deng, C. X. 2006. The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors. Int. J. Biol. Sci. 2:179-185.
10. DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., and Thompson, C. B. 2007. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA 104:19345-19350.
11. Denkert, C., Budczies, J., Weichert, W., Wohlgemuth, G., Scholz, M., Kind, T., Niesporek, S., Noske, A., Buckendahl, A., Dietel, M., and Fiehn, O. 2008. Metabolite profiling of human colon carcinoma-Deregulation of TCA cycle and amino acid turnover. Mol. Cancer 7:72-86.
12. Ewald, N., Schaller, M., Bayer, M., Akinci, A., Bretzel, R. G., Kloer, H. U., and Hardt, P. D. 2007. Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: A new screening concept for colorectal cancer. Anticancer Res. 27:1949-1952.
13. Furukawa, T., Fu, X., Kubota, T., Watanabe, M., Kitajima, M., and Hoffman, R. M. 1993. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res. 53:1204-1208. (Pubitemid 23087930)
14. Hanada, K., Ogawa, R., Son, K., Sasaki, Y., Kikkawa, A., Ichihara, S., and Ogata, H. 2006. Effects of indoxylsulfate on the in vitro hepatic metabolism of various compounds using human liver microsomes and hepatocytes. Nephron Physiol. 103:179-186.
15. Hemming, A. W., Gallinger, S., Greig, P. D., Cattral, M. S., Langer, B., Taylor, B. R., Verjee, Z., Giesbrecht, E., Nakamachi, Y., and Furuya, K. N. 2001. The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients. J. Gastrointest. Surg. 5:316-321.
16. Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., Esumi, H., and Soga, T. 2009. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69:4918-4925.
17. Holmes, E., and Antti, H. 2002. Chemometric contributions to the evolution of metabonomics: Mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst 127:1549-1557.
18. Issaq, H. J., Nativ, O., Waybright, T., Luke, B., Veenstra, T. D., Issaq, E. J., Kravstov, A., and Mullerad, M. 2008. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry. J. Urol. 179:2422-2426.
19. Jung, B. H., Bai, S. W., and Chung, B. C. 2004. Endogenous urinary steroids in premenopausal women with uterine leiomyomas. Int. J. Gynaecol. Obstet. 84:55-60.
20. 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines. J. Agric. Food Chem. 56:11589-11595.
21. Kim, K.-B., Chung, M. W., Um, S. Y., Oh, J. S., Kim, S. H., Na, M. A., Oh, H. Y., Cho, W. S., and Choi, K. H. 2008. Metabolomics and biomarker discovery: NMR spectral data of urine and hepatotoxicity by carbon tetrachloride, acetaminophen, and d-galactosamine in rats. Metabolomics 4:377-392.
22. Kim, K.-B., Kim, S. H., Um, S. Y., Chung, M. W., Oh, J. S., Jung, S. C., Kim, T. S., Moon, H. J., Han, S. Y., Oh, H. Y., Lee, B. M., and Choi, K. H. 2009a. Metabolomics approach to risk assessment: Methoxyclor exposure to rats. J. Toxicol. Environ. Health A 72:1352-1368.
23. Kim, K., Aronov, P., Zakharkin, S. O., Anderson, D., Perroud, B., Thompson, I. M., and Weiss, R. H. 2009b. Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol. Cell. Proteomics 8:558-570.
24. Kurhanewicz, J., Vigneron, D. B., Nelson, S. J., Hricak, H., MacDonald, J. M., Konety, B., and Narayan, P. 1995. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy. Urology 45:459-466.
25. Kurien, B. T., and Scofield, R. H. 1999. Mouse urine collection using clear plastic wrap. Lab. Anim. 33:83-86.
26. Lee, S. H., Yang, Y. J., Kim, K. M., and Chung, B. C. 2003. Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer. Cancer Lett. 201:121-131.
27. Ma, Y. L., Qin, H. L., Liu, W. J., Peng, J. Y., Huang, L., Zhao, X. P., and Cheng, Y. Y. 2009. Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer. Dig. Dis. Sci. doi 10.107/s10620-008-0665-4.
28. Niwa, T., and Ise, M. 1994. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J. Lab. Clin. Med. 124:96-104.
29. Ouchi, K. F., Yanagisawa, M., Sekiguchi, F., and Tanaka, Y. 2006. Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models. Cancer Chemother. Pharmacol. 57:693-702.
30. Park, J. C., Hong, Y. S., Kim, Y. J., Yang, J. Y., Kim, E. Y., Kwack, S. J., Ryu, D. H., Hwang, G. S., and Lee, B. M. 2009. A metabonomic study on the biochemical effects of doxorubicin in rats using (1) H-NMR spectroscopy. J. Toxicol. Environ. Health A 72:374-384.
31. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. 2002. Global cancer statistics, 2002. CA Cancer J. Clin. 55:74-108.
32. Perroud, B., Lee, J., Valkova, N., Dhirapong, A., Lin, P. Y., Fiehn, O., Kultz, D., and Weiss, R. H. 2006. Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol. Cancer 5:64-81.
33. Schlichtholz, B., Turyn, J., Goyke, E., Biernacki, M., Jaskiewicz, K., Sledzinski, Z., and Swierczynski, J. 2005. Enhanced citrate synthase activity in human pancreatic cancer. Pancreas 30:99-104.
34. Schmidt, M., Voelker, H. U., Kapp, M., Krockenberger, M., Dietl, J., and Kammerer, U. 2010. Glycolytic phenotype in breast cancer: Activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. J. Cancer Res. Clin. Oncol. 136:219-225.
35. Singh, K. K., Desouki, M. M., Franklin, R. B., and Costello, L. C. 2006. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol. Cancer 5:14-22.
36. Slupsky, C. M., Rankin, K. N., Wagner, J., Fu, H., Chang, D., Weljie, A. M., Saude, E. J., Lix, B., Adamko, D. J., Shah, S., Greiner, R., Sykes, B. D., and Marrie, T. J. 2007. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal. Chem. 79:6995-7004.
37. Sumiyoshi, H., Yasui, W., Ochiai, A., and Tahara, E. 1984. Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. Cancer Res. 44:4276-4280.
38. Taki, K., Nakamura, S., Miglinas, M., Enomoto, A., and Niwa, T. 2006. Accumulation of indoxylsulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure. J. Renal Nutr. 16:199-203.
39. 1H NMR-based metabolomics in rats. Anal. Chem. 81:4734-4741.
40. Upp, J. R., Jr., Beauchamp, R. D., Townsend, C. M., Jr., Barranco, S. C., Singh, P., Rajaraman, S., James, E., and Thompson, J. C. 1988. Inhibition of human gastric adenocarcinoma xenograft growth in nude mice by alpha-difluoromethylornithine. Cancer Res. 48:3265-3269.
41. Wacheck, V., Heere-Ress, E., Halaschek-Wiener, J., Lucas, T., Meyer, H., Eichler, H. G., and Jansen, B. 2001. Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model. J. Mol. Med. 79:587-593.
42. Wang, C. S., Wu, T. L., Tsao, K. C., and Sun, C. F. 2006. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker. Ann. Clin. Lab. Sci. 36:23-30.
43. Weljie, A. M., Newton, J., Mercier, P., Carlson, E., and Slupsky, C. M. 2006. Targeted profiling: Quantitative analysis of 1H NMR metabolomics data. Anal. Chem. 78:4430-4442.
44. Wiklund, S., Johansson, E., Sjostrom, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., Gottfries, J., Moritz, T., and Trygg, J. 2008. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 80:115-122.
45. Woo, H. M., Kim, K. M., Choi, M. H., Jung, B. H., Lee, J., Kong, G., Nam, S. J., Kim, S., Bai, S. W, and Chung, B. C. 2009. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin. Chim. Acta 400:63-69.
46. World Health Organization. 2009. Cancer. Fact sheet no. 97. Geneva: WHO.
47. Yasui, W, Sumiyoshi, H., Ochiai, A., and Tahara, E. 1986. Cholecystokinin inhibition of tumor growth and gastrin-stimulated cyclic adenosine 3':L5'-monophosphate metabolism in human gastric carcinoma in nude mice. Cancer Res. 46:740-743.
48. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma. Clin. Chim. Acta 401:8-13.